ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1276

Hyperglycemia and Risk of Osteoarthritis

Mona Walimbe1, Ann V. Schwartz2, Irina Tolstykh2, Charles E. McCulloch2, David T. Felson3, Cora E. Lewis4, Neil A. Segal5, Michael C. Nevitt2 and Nancy E. Lane6, 1Medicine, UCSF (University of California, San Francisco), San Francisco, CA, 2Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 3Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 4Preventive Medicine, The University of Alabama at Birmingham, Birmingham, AL, 5Orthopaedics and Rehabilitation, University of Iowa, Iowa City, IA, 6Internal Medicine, Center for Musculoskeletal Health, UC Davis School of Medicine, Sacramento, CA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Diabetes, insulin resistance and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects: Epidemiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose

Osteoarthritis (OA) is reported to be more prevalent in individuals with diabetes mellitus (DM).  Potential etiologies include advanced glycation endproducts, which reduce cartilage integrity, and obesity which increases the mechanical load on the knee.  We further explored the relationship of abnormal glucose metabolism and incident knee OA in a community based cohort with 84 months of follow up.

Methods

The Multicenter Osteoarthritis Study Group (MOST) is an NIH-funded longitudinal study of risk factors for knee OA in people age 50-79 years, with or at high risk of knee OA.  Subjects were eligible for this ancillary study if they did not have RKOA at baseline (Kellgren and Lawrence (KL) grade <2 bilaterally).  Subjects were excluded if they lacked follow up knee radiographs or if their baseline blood sample was not available.  A random sample diverse in baseline body mass index (BMI) of 1000 subjects (out of 1280 eligible subjects) was selected.  Fasting glucose (Unical DxC 800 Auto-analyser (Beckman Coulter, Fullerton, CA, USA) and free insulin (Luminex Milliplex Analyzer Model XYP 100/200 S, Austin, Texas) levels at baseline were measured on all subjects.  Subjects were categorized as DM based on any of the following: self-report DM, use of anti-diabetic medications or a fasting glucose at baseline of > 126 mg/dL.  The outcome was the cumulative incidence of RKOA between baseline and the 84-month follow-up visit, defined by either a KL grade > 2 or total knee replacement.  Knee-level pooled binary regression analysis was performed in men and women separately.  GEE (to account for within-subject correlation) was used to obtain risk ratios (95% CI) for incidence of RKOA predicted by: fasting glucose, insulin resistance (measured by homeostatic model assessment – insulin resistance (HOMA-IR)) and diabetes status.  Subjects who were taking insulin were excluded from models in which insulin resistance was analyzed. 

Results

Among the 1000 subjects (mean age 61+/-7.8 years, 58% women, mean BMI at baseline 29.1+/-4.9 kg/m2), there were 107 subjects with DM.  DM subjects were more likely to be male, non-white and have higher BMI.  Over the 84 months of follow-up, incidence of RKOA did not differ between diabetics compared to non-diabetics. In men, both elevated fasting glucose and HOMA-IR were associated with an increased risk of incident RKOA, but this effect did not persist after adjustment for BMI.  In women, HOMA-IR levels were associated with a decreased risk of incident RKOA after adjustment for BMI.  (Table) 

Conclusion

DM at baseline was not associated with incident RKOA in this cohort.  However, insulin resistance in women may be protective against the development of RKOA once the effect of high BMI is accounted for.  This finding needs to be replicated in additional studies.

TABLE: Risk Ratio for Incident Knee Osteoarthritis, stratified by sex

 

WOMEN

580 subjects/1160 knees/278 events

MEN

420 subjects/840 knees/137 events

 

Risk Ratio (95% CI) and p-values

Risk Ratio (95% CI) and p values

Baseline Predictor

Unadjusted Model

BMI-Adjusted Modela

Unadjusted Model

BMI-Adjusted Modela

Fasting glucose (per 1SD)

 

1.09 (0.96-1.23) 0.2

0.93 (0.81-1.07) 0.3

1.21 (1.04-1.42) 0.01

1.04 (0.88-1.23) 0.7

HOMA-IR (per 1SD)

 

1.05 (0.93-1.19) 0.4

0.81 (0.71-0.93) <0.01

1.26 (1.05-1.51) 0.01

1.03 (0.84-1.27) 0.8

Diabetes

 

0.92 (0.59-1.45) 0.7

0.63 (0.38-1.06) 0.08

1.49 (0.96-2.30) 0.08

1.10 (0.69-1.75) 0.7

aAdjusted for age, race, clinic site, visit, and body mass index  

 


Disclosure:

M. Walimbe,
None;

A. V. Schwartz,
None;

I. Tolstykh,
None;

C. E. McCulloch,
None;

D. T. Felson,
None;

C. E. Lewis,
None;

N. A. Segal,
None;

M. C. Nevitt,
None;

N. E. Lane,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hyperglycemia-and-risk-of-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology